{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:54:28Z","timestamp":1791154468780,"version":"4.1.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"955","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system that may result in a wide range of neurological symptoms and accumulating disability. Its course is unpredictable resulting in a changing pattern of clinical need. Diagnostic criteria for multiple sclerosis require objective evidence for dissemination in space and time. The diagnostic and management process should follow good practice guidelines with the person at the centre of the process. Appropriate support and information should be available from the time of diagnosis. Continuing education is key in enabling the person to actively participate in their management. In the event of an acute relapse the person should have direct access to the most appropriate local service. Provided medical causes have been excluded, corticosteroid treatment to hasten the recovery from the relapse should be considered. Management of an acute relapse should be comprehensive addressing any medical, functional, or psychosocial sequelae.<\/jats:p>","DOI":"10.1136\/pgmj.2004.029413","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T17:48:14Z","timestamp":1115315294000},"page":"302-308","source":"Crossref","is-referenced-by-count":81,"title":["Multiple sclerosis: diagnosis and the management of acute relapses"],"prefix":"10.1093","volume":"81","author":[{"given":"S M","family":"Leary","sequence":"first","affiliation":[{"name":"Rehabilitation Group, Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Porter","sequence":"additional","affiliation":[{"name":"Rehabilitation Group, Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Thompson","sequence":"additional","affiliation":[{"name":"Rehabilitation Group, Institute of Neurology , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,5,5]]},"reference":[{"key":"2023042408281144500_R1","volume-title":"Management of multiple sclerosis in primary and secondary care","author":"National Institute for Clinical Excellence","year":"2003"},{"key":"2023042408281144500_R2","volume-title":"Good medical practice for physicians","author":"Federation of Royal Colleges of Physicians of the U","year":"2004"},{"key":"2023042408281144500_R3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/WNL.42.5.991","article-title":"Life expectancy in patients attending multiple sclerosis clinics","volume":"42","author":"Sadovnick","year":"1992","journal-title":"Neurology"},{"key":"2023042408281144500_R4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S0317167100047351","article-title":"Epidemiology of multiple sclerosis: a critical overview","volume":"20","author":"Sadovnick","year":"1993","journal-title":"Can J Neurol Sci"},{"key":"2023042408281144500_R5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bmj.3.5777.725","article-title":"On the risk of multiple sclerosis according to the age at immigration to South Africa","volume":"iii","author":"Dean","year":"1971","journal-title":"BMJ"},{"key":"2023042408281144500_R6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"2023042408281144500_R7","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1212\/01.WNL.0000096175.39831.21","article-title":"Effect of relapses on development of residual deficit in multiple sclerosis","volume":"61","author":"Lublin","year":"2003","journal-title":"Neurology"},{"key":"2023042408281144500_R8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/112.1.133","article-title":"The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability","volume":"112","author":"Weinshenker","year":"1989","journal-title":"Brain"},{"key":"2023042408281144500_R9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/120.6.1085","article-title":"Primary progressive multiple sclerosis","volume":"120","author":"Thompson","year":"1997","journal-title":"Brain"},{"key":"2023042408281144500_R10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/brain\/116.1.117","article-title":"Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up","volume":"116","author":"Runmarker","year":"1993","journal-title":"Brain"},{"key":"2023042408281144500_R11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/brain\/122.10.1941","volume":"122","author":"Kremenchutzky","year":"1999","journal-title":"Brain"},{"key":"2023042408281144500_R12","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archneur.56.9.1138","article-title":"Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability","volume":"56","author":"Andersson","year":"1999","journal-title":"Arch Neurol"},{"key":"2023042408281144500_R13","first-page":"69","article-title":"A clinical and laboratory study of benign multiple sclerosis","volume":"58","author":"Thompson","year":"1986","journal-title":"Q J Med"},{"key":"2023042408281144500_R14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.20197","article-title":"Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann Neurol"},{"key":"2023042408281144500_R15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","article-title":"Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis","volume":"122","author":"Schumacher","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"2023042408281144500_R16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: Guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"2023042408281144500_R17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"2023042408281144500_R18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp.64.4.451","article-title":"Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK","volume":"64","author":"McDonnell","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.52.4.839","article-title":"Primary progressive multiple sclerosis: a clinical and MRI cross sectional study","volume":"52","author":"Stevenson","year":"1999","journal-title":"Neurology"},{"key":"2023042408281144500_R20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1531-8249(200006)47:6<831::AID-ANA21>3.0.CO;2-H","article-title":"Diagnostic criteria for primary progressive multiple sclerosis: a position paper","volume":"47","author":"Thompson","year":"2000","journal-title":"Ann Neurol"},{"key":"2023042408281144500_R21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/pmj.79.927.11","article-title":"Acute disseminated encephalomyelitis","volume":"79","author":"Garg","year":"2003","journal-title":"Postgrad Med J"},{"key":"2023042408281144500_R22","first-page":"223","volume-title":"McAlpine\u2019s multiple sclerosis.","author":"Matthews","year":"1998","edition":"3rd"},{"key":"2023042408281144500_R23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/brain\/113.2.291","article-title":"Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis","volume":"113","author":"Kesselring","year":"1990","journal-title":"Brain"},{"key":"2023042408281144500_R24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(85)90067-4","article-title":"To tell or not to tell the diagnosis of multiple sclerosis","volume":"ii","author":"Elian","year":"1985","journal-title":"Lancet"},{"key":"2023042408281144500_R25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01376517-199902000-00003","article-title":"The journey to multiple sclerosis: a qualitative study","volume":"31","author":"Koopman","year":"1999","journal-title":"J Neurosci Nurs"},{"key":"2023042408281144500_R26","first-page":"17","volume-title":"Current concepts in multiple sclerosis","author":"Robinson","year":"1991"},{"key":"2023042408281144500_R27","volume-title":"The views of people with MS about their needs","author":"Robinson","year":"1996"},{"key":"2023042408281144500_R28","volume-title":"Standards of healthcare for people with multiple sclerosis","author":"Freeman","year":"1997"},{"key":"2023042408281144500_R29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1191\/1352458503ms940oa","article-title":"Diagnosis of MS: a comparison of three different clinical settings","volume":"9","author":"Porter","year":"2003","journal-title":"Mult Scler"},{"key":"2023042408281144500_R30","first-page":"1423","article-title":"Effective physician-patient communication and health outcomes: a review","volume":"152","author":"Stewart","year":"1995","journal-title":"Can Med Assoc J"},{"key":"2023042408281144500_R31","volume-title":"Specialist nursing in MS\u2014the way forward: the key elements for developing MS specialist nurse services in the UK","author":"MS Trust, UKMSSNA RCN","year":"2001"},{"key":"2023042408281144500_R32","volume-title":"Helping you explain MS: a teaching resource for healthcare professionals","author":"Multiple Sclerosis Society","year":"2004"},{"key":"2023042408281144500_R33","volume-title":"An independent aid to your decision","author":"Medicines Partnership. Multiple sclerosis decisions"},{"key":"2023042408281144500_R34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1207\/S15324796ABM2601_01","article-title":"Self-management education: history, definition, outcomes, and mechanisms","volume":"26","author":"Lorig","year":"2003","journal-title":"Ann Behav Med"},{"key":"2023042408281144500_R35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2003-41138","article-title":"Current disease-modifying therapies in multiple sclerosis","volume":"23","author":"Kieseier","year":"2003","journal-title":"Semin Neurol"},{"key":"2023042408281144500_R36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2165\/00023210-200216080-00005","article-title":"Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis","volume":"16","author":"Khan","year":"2002","journal-title":"CNS Drugs"},{"key":"2023042408281144500_R37","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(85)92801-6","article-title":"Clinical viral infections and multiple sclerosis","volume":"i","author":"Sibley","year":"1985","journal-title":"Lancet"},{"key":"2023042408281144500_R38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00867354","article-title":"Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study","volume":"240","author":"Andersen","year":"1993","journal-title":"J Neurol"},{"key":"2023042408281144500_R39","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/brain\/awf098","article-title":"Prospective study on the relationship between infections and multiple sclerosis exacerbations","volume":"125","author":"Buljevac","year":"2002","journal-title":"Brain"},{"key":"2023042408281144500_R40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.48.2.312","article-title":"A multicentre, randomised, double-blind, placebo controlled trial of influenza immunisation in multiple sclerosis","volume":"48","author":"Miller","year":"1997","journal-title":"Neurology"},{"key":"2023042408281144500_R41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200102013440501","article-title":"Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group","volume":"344","author":"Confavreux","year":"2001","journal-title":"N Engl J Med"},{"key":"2023042408281144500_R42","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.59.12.1837","article-title":"Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines. Immunization and MS: a summary of published evidence and recommendations","volume":"59","author":"Rutschmann","year":"2002","journal-title":"Neurology"},{"key":"2023042408281144500_R43","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1212\/WNL.52.9.1737","article-title":"The relationship of MS to physical trauma and psychological stress. Report of the Therapeutic and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"52","author":"Goodin","year":"1999","journal-title":"Neurology"},{"key":"2023042408281144500_R44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.55.1.55","article-title":"Psychological stress and the subsequent appearance of new brain lesions in MS","volume":"55","author":"Mohr","year":"2000","journal-title":"Neurology"},{"key":"2023042408281144500_R45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bmj.327.7416.646","article-title":"Self reported stressful life events and exacerbations in multiple sclerosis: prospective study","volume":"327","author":"Buljevac","year":"2003","journal-title":"BMJ"},{"key":"2023042408281144500_R46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bmj.38041.724421.55","article-title":"Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis","volume":"328","author":"Mohr","year":"2004","journal-title":"BMJ"},{"key":"2023042408281144500_R47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N Engl J Med"},{"key":"2023042408281144500_R48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00330-7","article-title":"Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders","volume":"117","author":"Gold","year":"2001","journal-title":"J Neuroimmunol"},{"key":"2023042408281144500_R49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jnnp.45.2.179-a","article-title":"Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone","volume":"45","author":"Buckley","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jnnp.50.5.511","article-title":"A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects","volume":"50","author":"Milligan","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp.48.2.157","article-title":"Intravenous methylprednisolone for multiple sclerosis in relapse","volume":"48","author":"Barnes","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R52","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1212\/WNL.39.7.969","article-title":"Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS","volume":"39","author":"Thompson","year":"1989","journal-title":"Neurology"},{"key":"2023042408281144500_R53","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis","volume":"329","author":"Beck","year":"1993","journal-title":"N Engl J Med"},{"key":"2023042408281144500_R54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archopht.1995.01100020014004","article-title":"The optic neuritis treatment trial: three-year follow-up results","volume":"113","author":"Beck","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"2023042408281144500_R55","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp.56.11.1219","article-title":"Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose","volume":"56","author":"Alam","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R56","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(96)06453-7","article-title":"Randomised trial of oral and intravenous methylprednisolone in acute relapse of multiple sclerosis","volume":"349","author":"Barnes","year":"1997","journal-title":"Lancet"},{"key":"2023042408281144500_R57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jnnp.65.3.362","article-title":"Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom","volume":"65","author":"Tremlett","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R58","volume-title":"Cochrane Library.","author":"Filippini","year":"2000"},{"key":"2023042408281144500_R59","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1017\/S0317167100034053","article-title":"Cost analysis of methylprednisolone treatment of multiple sclerosis patients","volume":"25","author":"Robson","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"2023042408281144500_R60","first-page":"S152","article-title":"Developing a measure of patients\u2019 experiences of relapse management in multiple sclerosis. (Abstract)","volume":"9","author":"Riazi","year":"2003","journal-title":"Mult Scler"},{"key":"2023042408281144500_R61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.51.2.285","article-title":"Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects","volume":"51","author":"Lyons","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R62","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"key":"2023042408281144500_R63","first-page":"22","article-title":"Symptomatic management and rehabilitation in multiple sclerosis","volume":"71","author":"Thompson","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R64","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/jnnp.74.9.1225","article-title":"A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment","volume":"74","author":"Craig","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042408281144500_R65","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00415-003-0187-0","article-title":"Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis","volume":"250","author":"Liu","year":"2003","journal-title":"J Neurol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/81\/955\/302\/50025655\/postgradmedj-81-302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/81\/955\/302\/50025655\/postgradmedj-81-302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:33:19Z","timestamp":1682325199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/81\/955\/302\/7031849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":65,"journal-issue":{"issue":"955","published-online":{"date-parts":[[2005,5,5]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2004.029413","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,5]]},"published":{"date-parts":[[2005,5,1]]}}}